Insertion of human interleukin-15 into pJET vector for anti-cancer vaccine development
Cancer is claimed to be the first killer for human beings nowadays. Tumours have high capability to escape from host immune responses, thus currently there are still no effective immunotherapeutic strategies that can be used to cure cancer. Today, cytokines are highly i...
Saved in:
Main Author: | Ng, Huay Shin |
---|---|
Format: | Project Paper Report |
Language: | English |
Published: |
2015
|
Online Access: | http://psasir.upm.edu.my/id/eprint/85031/1/FBSB%202015%20116%20-%20IR.pdf http://psasir.upm.edu.my/id/eprint/85031/ |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cloning of human- interleukin-12 into pJET cloning vector for anti-cancer vaccine development
by: Che Ani, Muhamad Alhapis
Published: (2015) -
A strategy for in-house production of a positive selection cloning vector from the commercial pJET1.2/blunt cloning vector at minimal cost
by: Nawawi, Omar, et al.
Published: (2022) -
Safety and efficacy of recombinant newcastle disease virus expressing human interleukin-12 as a potential vaccine in breast cancer
by: Mohamed Amin, Zahiah
Published: (2019) -
Performance Evaluation of Phorizon and Pjet_Veot Reservation Schemes for Optical Burst Switching
by: Silvarajah, Deepalaxmi
Published: (2006) -
The role, involvement and function(s) of interleukin-35 and interleukin-37 in disease pathogenesis
by: Bello, Ramatu Omenesa, et al.
Published: (2018)